Taher Nassar
- Molecular Biology
- Pharmaceutical Science top 0.5%
- Biomaterials top 5%
- Epidemiology top 10%
- Cancer Research top 10%
- Co-authors
- Simon BenitaAbd Al‐Roof HigaziAbdullah Haj‐YehiaDouglas B. CinesSa’ed AkkawiKhalil BdeirNour KarraOuri Schwob
- Topics
- Protease and Inhibitor Mechanisms (13 papers)Advanced Drug Delivery Systems (10 papers)Drug Solubulity and Delivery Systems (7 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Taher Nassar
50 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 508
- Pharmaceutical Science 415
- Biomaterials 264
- Epidemiology 252
- Cancer Research 250
Countries citing papers authored by Taher Nassar
This map shows the geographic impact of Taher Nassar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taher Nassar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taher Nassar more than expected).
Fields of papers citing papers by Taher Nassar
This network shows the impact of papers produced by Taher Nassar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taher Nassar. The network helps show where Taher Nassar may publish in the future.
Co-authorship network of co-authors of Taher Nassar
This figure shows the co-authorship network connecting the top 25 collaborators of Taher Nassar. A scholar is included among the top collaborators of Taher Nassar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taher Nassar. Taher Nassar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 21 | |
| 3 | 4 | |
| 4 | 36 | |
| 5 | 4 | |
| 6 | 50 | |
| 7 | 88 | |
| 8 | 32 | |
| 9 | 19 | |
| 10 | 67 | |
| 11 | 71 | |
| 12 | 31 | |
| 13 | 37 | |
| 14 | 60 | |
| 15 | 43 | |
| 16 | 24 | |
| 17 | 12 | |
| 18 | 74 | |
| 19 | 47 | |
| 20 | 54 |
About Taher Nassar
Taher Nassar is a scholar working on Pharmaceutical Science, Cancer Research and Biochemistry, having authored 51 papers that have together received 1.9k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Advanced Drug Delivery Systems (10 papers) and Drug Solubulity and Delivery Systems (7 papers). The work is most often cited by research in Pharmaceutical Science (415 citations), Hematology (228 citations) and Biomaterials (264 citations). Taher Nassar has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Simon Benita, Abd Al‐Roof Higazi, Abdullah Haj‐Yehia, Douglas B. Cines, Sa’ed Akkawi, Khalil Bdeir, Nour Karra, Ouri Schwob, Mark Tarshis and Abraham Nyska. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.